特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
914041

獣医腫瘍学の世界市場:規模、シェア、見通し、機会分析

Veterinary Oncology Market, by Animal Type, by Therapy Type, by Mode of Administration, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2026

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 225 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.56円
獣医腫瘍学の世界市場:規模、シェア、見通し、機会分析
出版日: 2019年08月26日
発行: Coherent Market Insights
ページ情報: 英文 225 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートは世界の獣医腫瘍学市場について調査しており、市場機会や動向、成長および阻害要因、動物の種類・治療タイプ・投与方法・用途・流通チャネル・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 調査の目的および前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の概要

  • レポートの説明
  • エグゼクティブサマリー
  • Coherent Opportunity Map (COM)

第3章 市場力学、規制、動向分析

  • 市場力学
  • 影響分析
  • 獣医腫瘍学の予防・管理のための取り組み
  • 放射線療法
  • 市場動向
  • 製品回収
  • 疫学
  • 主な開発
  • 猫のがん
  • 犬のがん
  • 獣医学で一般的に使用される化学療法剤
  • 規制シナリオ
  • 獣医学:特許情報
  • 動物の癌:意識向上キャンペーン
  • 合併・買収
  • PEST分析

第4章 市場分析:動物の種類別

  • イントロダクション
  • コンパニオンアニマル
  • ウマ
  • ネコ
  • 家畜動物

第5章 市場分析:治療タイプ別

  • イントロダクション
  • 化学療法
  • 併用療法
  • 免疫療法
  • 標的療法

第6章 市場分析:投与方法別

  • イントロダクション
  • 経口
  • 静脈内

第7章 市場分析:用途別

  • イントロダクション
  • 犬のリンパ腫
  • 骨肉腫(OSA)
  • 肥満細胞がん
  • 黒色腫
  • 多発性骨髄腫

第8章 市場分析:流通チャネル別

  • イントロダクション
  • 病院薬局
  • 政府機関
  • 小売薬局

第9章 市場分析:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • アフリカ
  • 中東

第10章 競合情勢

  • 企業プロファイル
    • Zoetis Inc.
    • Elanco
    • AB Science
    • Boehringer Ingelheim International GmbH
    • Zenoaq
    • VetDC
    • Morphogenesis, Inc.
    • Karyopharm Therapeutics, Inc.
    • Regeneus Ltd.
    • AdvaVet, Inc.
    • Rhizen Pharmaceutical SA
  • アナリストの見解

第11章 セクション

  • 参照資料
  • 調査方法
  • 当社について
目次

Veterinary oncology is subspecialty of veterinary medicine that deals with the diagnosis and treatment of cancer in animals. With emerging technologies, the use of biotechnology products in veterinary medicines is increasing. Despite the costs that many times accompany the development of novel biotechnological products, recombinant virus vector vaccines, recombinant proteins such as bioactive cytokines and immunotherapeutic allergens, therapeutic antibodies, and oncolytic viruses are the result of advancements in biotechnology for veterinary medicines. The benefits associated with using biotechnology products are large-scale production, reduced costs, long-term action, and multiple antigen vaccines.

Market Dynamics

  • Increasing prevalence of veterinary cancer is expected to boost the global veterinary oncology market growth during the forecast period. For instance, according to the Veterinary Cancer Society, in 2016, cancer is the leading cause of death in 47% of dogs diagnosed with cancer over the age of 10 years; and 32% of cats, where Feline Leukaemia Virus (FeLV) is one of the leading cause of lymphoma in cats. Moreover, according to the Animal Cancer Foundation in 2015, around 6 million new cancer cases in dogs and cats are recorded, annually, in the U.S., of which one-third of all tumors in dogs are skin tumors, while around 20% are mast cell tumors.
  • However, adverse effects associated with chemotherapies, immunotherapies, and targeted therapies such as diarrhoea, anorexia, decreased appetite, lethargy, neutropenia, emesis, lameness, severe weight loss, and musculoskeletal disorder are major factors restraining the veterinary oncology market growth.

Key features of the study:

  • This report provides in-depth analysis of the global veterinary oncology market, market size (US$ Mn), and compound annual growth rate (CAGR %) during the forecast period: 2019 - 2026, considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players operating in this market
  • It profiles key players in the global veterinary oncology market based on the following parameters-company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., and Rhizen Pharmaceutical SA
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global veterinary oncology market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for global veterinary oncology market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Veterinary Oncology Market, By Animal Type:
  • Companion Animal
    • Equine
    • Canine
    • Feline
  • Livestock Animal
  • Global Veterinary Oncology Market, By Therapy Type:
  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy
  • Global Veterinary Oncology Market, By Mode of Administration:
  • Oral
  • Intravenous
  • Global Veterinary Oncology Market, By Application:
  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
  • Global Veterinary Oncology Market, By Distribution Channel:
  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
  • Global Veterinary Oncology Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
    • By Animal Type:
  • Companion Animal
  • Equine
  • Canine
  • Feline
  • Livestock Animal
    • By Therapy Type:
  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy
    • By Mode of Administration:
  • Oral
  • Intravenous
    • By Application:
  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
    • By Distribution Channel:
  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
  • Europe
    • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
    • By Animal Type:
  • Companion Animal
  • Equine
  • Canine
  • Feline
  • Livestock Animal
    • By Therapy Type:
  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy
    • By Mode of Administration:
  • Oral
  • Intravenous
    • By Application:
  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
    • By Distribution Channel:
  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
  • Asia Pacific
    • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
    • By Animal Type:
  • Companion Animal
  • Equine
  • Canine
  • Feline
  • Livestock Animal
    • By Therapy Type:
  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy
    • By Mode of Administration:
  • Oral
  • Intravenous
    • By Application:
  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
    • By Distribution Channel:
  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
    • By Animal Type:
  • Companion Animal
  • Equine
  • Canine
  • Feline
  • Livestock Animal
    • By Therapy Type:
  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy
    • By Mode of Administration:
  • Oral
  • Intravenous
    • By Application:
  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
    • By Distribution Channel:
  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
  • Middle East
    • By Country/Region:
  • GCC
  • Israel
  • Rest of Middle East
    • By Animal Type:
  • Companion Animal
  • Equine
  • Canine
  • Feline
  • Livestock Animal
    • By Therapy Type:
  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy
    • By Mode of Administration:
  • Oral
  • Intravenous
    • By Application:
  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
    • By Distribution Channel:
  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
    • By Animal Type:
  • Companion Animal
  • Equine
  • Canine
  • Feline
  • Livestock Animal
    • By Therapy Type:
  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy
    • By Mode of Administration:
  • Oral
  • Intravenous
    • By Application:
  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
    • By Distribution Channel:
  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies
  • Company Profiles
    • Zoetis Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
    • Elanco
    • AB Science
    • Boehringer Ingelheim International GmbH
    • Zenoaq
    • VetDC
    • Morphogenesis, Inc.
    • Karyopharm Therapeutics, Inc.
    • Regeneus Ltd.
    • AdvaVet, Inc.
    • Rhizen Pharmaceutical SA

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Animal Type
    • Market Snippet, By Therapy Type
    • Market Snippet, By Mode of Administration
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Initiatives for Prevention and Control of Veterinary Oncology
  • Radiation Therapy
  • Market Trends
  • Product Recall
  • Epidemiology
  • Key Developments
  • Cancers in Cats
  • Cancers in Dogs
  • Chemotherapy Agents Commonly used in Veterinary Medicine
  • Regulatory Scenario
  • Veterinary Medicines: Patent Information
  • Veterinary Cancer: Awareness Campaign
  • Mergers and Acquisitions
  • PEST Analysis

4. Global Veterinary Oncology Market, By Animal Type, 2019 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Companion Animal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Equine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Canine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Feline
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Livestock Animal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)

5. Global Veterinary Oncology Market, By Therapy Type 2019 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Chemotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Combination Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Immunotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Targeted Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)

6. Global Veterinary Oncology Market, By Mode of Administration , 2019 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)

7. Global Veterinary Oncology Market, By Application, 2019 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Canine Lymphoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Osteosarcoma (OSA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Mast Cell Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Melanoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Multiple Myeloma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)

8. Global Veterinary Oncology Market, By Distribution Channel, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Government Agencies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2026, (US$ Million)

9. Global Veterinary Oncology Market, By Region, 2016 - 2026 (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Animal Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2019 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Animal Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2019 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Animal Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2019 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Animal Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2019 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Animal Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2019 - 2026, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Animal Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Mode of Administration, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2019 - 2026, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2019 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

10. Competitive Landscape

  • Company Profiles
    • Zoetis Inc.*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Elanco
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • AB Science
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Boehringer Ingelheim International GmbH
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Zenoaq
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • VetDC
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Morphogenesis, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Karyopharm Therapeutics, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Regeneus Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • AdvaVet, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Rhizen Pharmaceutical SA
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.